TAKAYASU ARTERITIS
Clinical trials for TAKAYASU ARTERITIS explained in plain language.
Never miss a new study
Get alerted when new TAKAYASU ARTERITIS trials appear
Sign up with your email to follow new studies for TAKAYASU ARTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Surgery may boost survival in rare vascular disease
Disease control CompletedThis study looked back at 78 patients with severe Takayasu arteritis, a rare inflammatory disease that damages the body's largest arteries. Researchers compared whether surgery or medication alone led to better survival rates. The goal was to understand which approach helps patie…
Matched conditions: TAKAYASU ARTERITIS
Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Common drug tested for hidden power against debilitating autoimmune symptoms
Symptom relief CompletedThis study tested whether a very low dose of an existing medication (naltrexone) could improve daily life for people with several types of vasculitis, a group of autoimmune diseases that cause blood vessel inflammation. The trial involved 60 adults whose disease was stable but wh…
Matched conditions: TAKAYASU ARTERITIS
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Apr 03, 2026 14:42 UTC